Related Experiment Video
Updated: May 10, 2026

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study
Hoda M Malaty1, Bincy P Abraham, Seema Mehta
1Department of Medicine, Houston, TX, USA ; Department of Pediatrics, Houston, TX, USA.
Insights
Pediatric ulcerative colitis (UC) presents a significant risk for colectomy and extraintestinal manifestations (EIMs). Girls are more prone to developing proctitis, highlighting the need for tailored therapeutic interventions in pediatric UC management.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Epidemiology
Background:
- The natural history and long-term outcomes of pediatric ulcerative colitis (UC) remain under-researched.
- Understanding disease progression in children is crucial for effective management.
Purpose of the Study:
- To investigate the natural history of ulcerative colitis in a pediatric cohort.
- To determine the incidence of colectomy, proctitis, and extraintestinal manifestations (EIMs) in children with UC.
Main Methods:
- Retrospective analysis of 115 children diagnosed with UC between 1986 and 2003.
- Evaluation of clinical, radiologic, endoscopic, and histologic data.
- Assessment of colectomy, proctitis, and EIMs at diagnosis and end of follow-up.
Main Results:
- 16% cumulative colectomy rate by 10 years; 20% of children experienced EIMs (48% arthritis, 35% sclerosing cholangitis).
- Girls had a higher likelihood of developing proctitis (29 patients).
- Disease extension occurred in a significant proportion of patients, with higher BMI Z-scores at follow-up.
Conclusions:
- Pediatric UC is linked to substantial rates of EIMs and colectomy, independent of age, gender, or race.
- Girls exhibit a higher prevalence of proctitis.
- Further understanding of UC's clinical course is vital for optimizing pediatric treatment strategies.
Background:
The natural history of ulcerative colitis (UC) has been poorly studied in children.
Methods:
We performed a retrospective study in children diagnosed with UC with a follow-up. The diagnosis of UC was based on clinical, radiologic, endoscopic, and histologic examinations. We estimated the occurrence of colectomy, proctitis, and extraintestinal manifestations (EIMs) at the onset of the diagnosis and at the end of the study period.
Results:
We identified 115 UC patients between 1986 and 2003 with a mean age at diagnosis of 10.6 ± 5.1 years. The cumulative rate of colectomy was 4.1% at 1 year, and 16% at 10 years. EIMs were experienced by 20% of the children; 48% had arthritis, 35% had sclerosing cholangitis, and 17% had aphthous stomatitis. Proctitis was noted in 29 patients and it was not associated with an increased risk of colectomy (relative risk = 1.4; 95% CI = 0.7-4.5), and girls were twice more likely to develop proctitis. The pathologic reading for disease extensions was recorded for all children at entry and only 62 children had pathological results at maximum follow-up. At entry, 25% of the children only had ulcerative proctitis (E1) localization, 40% had left-sided UC (E2), and 35% had extensive UC (E3). Among the patients with E1 localization, 20% had progressed to E2 and 80% had progressed to E3; among the patients with E2 localization, 40% had progressed to E3. Age, gender, and EIMs at time of diagnosis were not associated with extension of disease at maximal follow-up. The Z score of body mass index (BMI) of children was significantly higher at the end of the study. At diagnosis, 85% of patients received 5-aminosalicyclic acid, 60% received steroids, and 11% received an immunomodulator. The majority of patients were still using systemic steroids at and after 5 years from their entry date. Only 32 of the 91 children on steroids did not receive an immunomodulator.
Conclusion:
Pediatric UC is associated with high rates of EIMs and colectomy that are not dependent on age, gender, or race, but is associated with a high rate of proctitis among girls. Understanding the clinical course of UC can optimize therapeutic interventions.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
